Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMA House of Delegates

This article was originally published in The Tan Sheet

Executive Summary

Will consider a proposed resolution suggesting Medicaid coverage of OTC drugs at the group's June 13-17 meeting in Chicago. The resolution, submitted by the American Medical Association's student section, urges the association to "study possible changes in Medicaid coverage policy such that Medicaid pay for OTC drugs when, by a consensus of current medical knowledge, those drugs are deemed the drug of choice for a given diagnosis or illness." The resolution notes that some state Medicaid programs do not cover certain OTC products, putting physicians "in a situation wherein they must prescribe an alternative medication which is often less efficacious, more toxic and more expensive to Medicaid".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081510

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel